Galafold 123 MG
Ended Awarded
- Contract number
- 36C24526N0188
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,891
Award facts
- Contract value 100% obligated
- $21,891.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $21,891.21 to Amicus Therapeutics US, LLC for the supply of Galafold 123 mg, an enzyme replacement therapy used to treat Fabry disease. This firm fixed-price delivery order, awarded on December 12, 2025, with a completion date of December 16, 2025, will be fulfilled at a facility in Philadelphia, PA. The contract does not utilize a set-aside designation and represents a task order under the parent Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), valued at approximately $13 million and valid through August 2029.
Amicus Therapeutics US, LLC, a biopharmaceutical subsidiary specializing in treatments for rare genetic diseases, serves as the prime contractor with no subcontractor involvement. The company has established itself as a key supplier of Galafold to the VA across multiple VISN regions, including VISN 5, 7, 9, and 19. This delivery order supports the VA's mission to provide specialized pharmaceutical products to veterans, with the short performance timeline typical of emergency pharmaceutical procurement needs within the federal healthcare system.
Quick answers
Who was awarded contract 36C24526N0188?
36C24526N0188 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 12, 2025.
How much is contract 36C24526N0188 worth?
The government has obligated $21,891 on 36C24526N0188.
Is contract 36C24526N0188 an order under another contract?
Yes. 36C24526N0188 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0188 competed?
The extent of competition for 36C24526N0188 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award